Fuzheng Wei

Associate Director, Business Development at Boehringer Ingelheim Biopharmaceuticals

Presenter

Boehringer Ingelheim has been active in China since 1994. Over the years, the company’s presence has grown significantly, now employing more than 3,000 people across the country. Among other offices and facilities in various Chinese cities, Shanghai stands out due to its strategic role for the company. It is the seat of the headquarters of Boehringer Ingelheim in China‘s mainland, Hong Kong and Taiwan, and both business areas (Human Pharma, Animal Health) operate in the metropolis.